Viewing Study NCT03978520


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2025-12-26 @ 3:28 AM
Study NCT ID: NCT03978520
Status: COMPLETED
Last Update Posted: 2023-07-21
First Post: 2019-06-03
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)
Sponsor: AbbVie
Organization: